Farnesyl pyrophosphate synthase
| GO Term | Evidence Code | Reference |
|---|---|---|
| cholesterol biosynthetic process | ||
| cholesterol biosynthetic process | ||
| geranyl diphosphate biosynthetic process | ||
| farnesyl diphosphate biosynthetic process |
| GO Term | Evidence Code | Reference |
|---|---|---|
| nucleoplasm |
|
|
| cytoplasm | ||
| cytoplasm | ||
| mitochondrial matrix | ||
| peroxisome |
| GO Term | Evidence Code | Reference |
|---|---|---|
| RNA binding | ||
| dimethylallyltranstransferase activity | ||
| dimethylallyltranstransferase activity | ||
| (2E,6E)-farnesyl diphosphate synthase activity | ||
| (2E,6E)-farnesyl diphosphate synthase activity |
| Pathway Name | Organism |
|---|---|
| Activation of gene expression by SREBF (SREBP) | Homo sapiens |
| Lanosterol biosynthesis | Homo sapiens |
| DO ID | Disease Name | Source |
|---|---|---|
| DOID:3805 | porokeratosis |
GlyCosmos is a member of the GlySpace Alliance together with GlyGen and Glycomics@ExPASy.
Supported by JST NBDC Grant Number JPMJND2204
Partly supported by NIH Common Fund Grant #1U01GM125267-01
This work is licensed under Creative Commons Attribution 4.0 International
GlyCosmos Portal v4.5.0
Last updated: April 6, 2026